The Impact of COVID-19 on Hypertrophic Cardiomyopathy Patients: Causes, Predictors, and Outcomes of 30-Day Readmission

Presenter/Author Information

Zaid Abood MD, Cardiovascular and Thoracic Services, Aurora St. Luke’s Medical Center, Advocate HealthFollow
M Fuad Jan MBBS, MD, Interventional Cardiology, Aurora St. Luke’s Medical Center, Advocate HealthFollow
Arshad Jahangir MD, Electrophysiology, Aurora St. Luke’s Medical Center, Advocate HealthFollow
A Jamil Tajik MD, Cardiology, Aurora St. Luke’s Medical Center, Advocate HealthFollow

Recommended Citation

Abood Z, Jan MF, Jahangir A, Tajik AJ. The Impact of COVID-19 on Hypertrophic Cardiomyopathy Patients: Causes, Predictors, and Outcomes of 30-Day Readmission. Presented at Scientific Day; May 22, 2024; Milwaukee, WI.

Affiliations

Aurora Cardiovascular and Thoracic Services, Aurora St. Luke’s Medical Center

Presentation Notes

Presented at Scientific Day; May 22, 2024; Milwaukee, WI.

Full Text of Presentation

wf_yes

Document Type

Oral/Podium Presentation